You are subscribed to the Dermatology Times eNews.

Dermatology Times eNews

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

June 5, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

FDA approves two melanoma drugs

The Food and Drug Administration approved two drugs and a companion diagnostic for the treatment of advanced metastatic melanoma. » More

Share »facebook twitter LinkedIn Google+

Comorbidities accompany alopecia areata

Comorbidities such as autoimmune diseases and mental health problems are common in patients with alopecia areata, study results suggest. » More

Share »facebook twitter LinkedIn Google+

fyi...

4.5 million

 

Number of people in the United States who have alopecia areata

Source: New England Journal of Medicine

ArteFill may serve as acne scar therapy

ArteFill (Suneva Medical) may fill a void in the long-term treatment of acne scarring, initial study data indicates. » More

Share »facebook twitter LinkedIn Google+

IBD boosts melanoma risk

Patients who have inflammatory bowel disease (IBD) are at an increased risk of melanoma, according to study results presented recently. » More

Share »facebook twitter LinkedIn Google+

New Job Opportunities

AZ • Palm Canyon Dermatology

CA • Arch Health Partners, Inc

CA • Integrated Dermatology

CO • Integrated Dermatology

CT • Integrated Dermatology

DC • Integrated Dermatology

FL • Integrated Dermatology

LA • Ochsner Health System

New Job Opportunities

NH • Integrated Dermatology

NJ • David A. High MD

NY • Advanced Dermatology Associates

NY • Garden City Dermatology

NY • Queens Crossing Dermatology

PA • Dermatology Associates of Lancaster

TN • Integrated Dermatology

TX • Integrated Dermatology

 
Powered by Modern Medicine Advanstar Medical Communications Group